Eyeworld

NOV 2018

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1043093

Contents of this Issue

Navigation

Page 61 of 90

59 EW CORNEA November 2018 by Michelle Stephenson EyeWorld Contributing Writer device years ago see a provider who isn't familiar with the device. The provider will tell the patient that he or she is going to dilate the pupil. The patient will have to tell the provider that it's plastic and doesn't dilate. It's quite realistic," Dr. Snyder said. He noted that the matches are good, but they are not all perfect. "Sometimes, it might be slightly lighter, slightly darker, slightly greener, or slightly bluer, but the matches at conversational range are quite excellent. I tell patients that at cocktail party distance, it's unlikely someone will be able to tell," he said. There are two models of the HumanOptics device: a fiber-free and a fiber-containing model. "The fiber-free model is generally inject- ed or placed into the capsular bag or ciliary sulcus if there's strong capsular and zonular support," Dr. Miller explained. "It is not supposed to be sutured in place. If you think you're going to need to suture-fixate a device, which occurs in the major- ity of cases, then you need to make sure you order the fiber-containing model. We're all still trying to figure out how to size these. The devices come in a standard diameter of 12.8 mm, and this size seems to work HumanOptics artificial iris According to Dr. Miller, the Hu- manOptics artificial iris is just becoming commercially available. "For the next 2–4 years, we will be in limbo. We will have to go from one insurance company to the next, and do the same for the various government programs, to get them to pay for the device and the surgery to implant it. New CPT and HCPCS codes will have to be created. We will need to sort out whether pa- tients will be allowed to pay for the device upfront and be reimbursed by their insurance. It's going to be an interesting few years. I think the device may be less available during the next 4 years than it was during the clinical trial because of the red tape we're likely to encounter," he said. According to Dr. Snyder, the device is customized to look like the patient's other iris. "People who are congenital aniridics and are born with no irises will need to find a picture of eyes they like because they are custom-made one at a time. Each device is handmade to match the index photo that's taken of the fellow eye. They are made out of a flexible silicone, and there's a tex- tured surface that is much like the native iris. Occasionally I will have a patient in whom I implanted a a bad fist injury can damage the pupil and cause a mydriasis with- out rupturing the globe. On other occasions, the globe ruptures. As an example, one of my patients was at Dodger Stadium when a foul ball was hit in his direction. It hit him right in the face, fractured his orbit in several places, and blew out his eye," Dr. Miller said. Michael Snyder, MD, Cincin- nati Eye Institute, Cincinnati, said that many of these patients have multiple holes or openings in the iris, which can cause multiple imag- es. "They will look at one object and they'll see three. They may see one primary object, a shadow image be- hind it, and a blurred image on top of it, all of the same thing. That's really unpleasant," he said. Additionally, these patients experience a significant reduction in contrast. Dr. Snyder compares it to watching a movie in a dark room and having someone open the door to a well-lit hallway. "For the person who has an abnormal iris, light is getting through and around the defect. It's the defocused light that impacts vision. These patients are living with this all day long. It's not just the light sensitivity, it's not just the halos, and it's not just the glare. It's also contrast sensitivity, shadow images, and multiple images. These iris devices can prevent excess light from entering the eye, whether fo- cused or defocused, so that the eye is receiving an acceptable amount of light," he said. A look at the cosmetic and functional benefits of artificial iris implants I n May, the U.S. Food and Drug Administration (FDA) approved the first artificial iris implant (CustomFlex Artificial Iris, HumanOptics, Erlangen, Ger- many) in the country, and it is just now coming to the marketplace. Iris implants have both cosmetic and functional benefits for patients with congenital or acquired iris defects. "Congenital defects usually fall into the complete aniridia or coloboma categories," said Kevin M. Miller, MD, Kolokotrones Chair in Ophthalmology, Stein Eye Insti- tute, University of California, Los Angeles. "Other congenital defects include oculocutaneous albinism, where the iris is structurally OK but is missing pigment, iridocorneal endothelial syndrome, and other dysgenesis syndromes." Dr. Miller said the overwhelm- ing majority of his patients who would benefit from an artificial iris have suffered either surgical trauma, which is less common, or blunt or penetrating trauma. "Examples of penetrating trauma include scissors slicing into the eye or a bullet or glass going into the eye. Then there are defects from blunt trauma, like fist and racquetball injuries. Blunt traumas can be further divided into blunt with rupture of the eye or blunt without rupture. For example, Artificial iris implants This slit lamp image shows a CustomFlex Artificial Iris in the capsular bag, secured temporally with a sutured Cionni CTR. Preop image (above) of a patient who suffered a ruptured globe injury OS and the postop image (below) following sutured IOL and CustomFlex Artificial Iris placement Source: Michael Snyder, MD continued on page 60 Device focus

Articles in this issue

Archives of this issue

view archives of Eyeworld - NOV 2018